Expands Potential Market and Study Opportunities for HTG Transcriptome Panel TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has now expanded the potential markets and applications for its pioneering HTG Transcriptome Panel (HTP). Since launching HTP with commercial availability in […]

— Further enables customers to convert from SNP microarray to NGS-based approach — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of synthetic DNA using its silicon platform, today announced the launch of the Twist 96-Plex Library Prep Kit, a high-performance, cost-effective preparation kit […]

AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products. A powerful technology, widely used in genome science, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) / Cas9 is a simple and efficient editing tool which allows for specific genome disruption and replacement facilitating the manipulation of […]

TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that internationally renowned physician-scientist Jerald Radich, M.D., a pioneer in the fields of leukemia research and molecular genetics, has joined HTG’s Therapeutics Scientific Advisory Board. Dr. Radich adds to the company’s […]

SAN DIEGO — Bionano Genomics, Inc. (BNGO), provider of optical genome mapping (OGM) solutions on the Saphyr® system and the leading software for genomic data visualization, interpretation and reporting, today announced the launch of version 6.1 of BioDiscovery’s NxClinical software with expanded capabilities for next-generation sequencing (NGS) data in genetic diseases and cancer. NxClinical is an […]

Oxford expansion supports U.K. customers with fast turnaround time on research products, and technical support OXFORD, England —GenScript Biotech Corp., a global biotechnology group, announced today that it has expanded operations in the United Kingdom with new offices and a fully functional logistics center in Oxford. The facility supports U.K. customers with fast delivery of […]

Männedorf, Switzerland – Tecan Group Ltd. (SIX Swiss Exchange: TECN) announced today that its Board of Directors will propose the election of Myra Eskes as a new independent member of the Board at Tecan’s next Annual General Meeting on April 12, 2022. Tecan, a pioneer and global leader in laboratory automation for life sciences and diagnostics, expanded into the medical devices sector with the acquisition of Paramit Corporation in August 2021. With more than […]

NEXT-GENERATION SEQUENCING PLATFORM WILL PROVIDE UP TO THREE TIMES MORE DATA OUTPUT PER HOUR THAN OTHER BENCHTOP INSTRUMENTS, WHILE OFFERING FLEXIBLE RUN CAPACITY – LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the commercial launch of […]

Collaboration aims to combine Twist’s proprietary synthetic antibody libraries and sophisticated bioinformatics expertise with Sosei Heptares’ world-leading StaR® (stabilized receptor) platform to generate novel antibody leads to disease-relevant GPCR targets SOUTH SAN FRANCISCO, Calif.–Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, […]

Research Triangle Park, NC  – – EpiCypher, Inc. announces the co-exclusive licensing of CUT&RUN / CUT&Tag technology from Fred Hutchinson Cancer Research Center. This agreement strengthens EpiCypher’s intellectual property portfolio that includes CUT&RUN / CUT&Tag workflows for both Research Use Only (RUO) and diagnostics applications. EpiCypher is now firmly established as the leading commercial developer […]